10X GENOMICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.59 USD | +2.57% |
|
-1.25% | -50.70% |
| 04-18 | Deutsche Bank Cuts Price Target on 10x Genomics to $55 From $60, Keeps Buy Rating | MT |
| 03-26 | 10x Genomics, Inc. Commercially Launches Visium HD Spatial Gene Expression Assay | CI |
Chart calendar 10x Genomics, Inc.
ec509d93ca8fedfe009a053a5add6a._cxa7hW2f9CBwtOAPLO5C0J0QwOXj1FXDc0bLxSjQBM.h44TuUfCPb70i6HxDYbdeAxHBHenxwchb6NYSGLyKEyfvS-LUI8QiqywpA~5e622a048cfd88f07669f39d239cd5b2
Upcoming events on 10x Genomics, Inc.
Past events on 10x Genomics, Inc.
| 05/03/2024 19:50 | TD Cowen Health Care Conference |
| 15/02/2024 21:30 | Q4 2023 Earnings Call |
| 15/02/2024 21:05 | Q4 2023 Earnings Release |
| 08/01/2024 17:00 | JPMorgan Healthcare Conference |
| 14/11/2023 16:00 | Stephens Investment Conference |
| 02/11/2023 20:30 | Q3 2023 Earnings Call |
| 02/11/2023 20:05 | Q3 2023 Earnings Release |
| 12/09/2023 13:50 | Morgan Stanley Global Healthcare Conference |
| 03/08/2023 21:30 | Q2 2023 Earnings Call |
| 03/08/2023 21:05 | Q2 2023 Earnings Release |
| 14/06/2023 21:30 | Annual General Meeting |
| 10/05/2023 22:20 | Bank of America Healthcare Conference |
| 03/05/2023 21:30 | Q1 2023 Earnings Call |
| 03/05/2023 21:05 | Q1 2023 Earnings Release |
| 06/03/2023 16:10 | Cowen Health Care Conference |
| 15/02/2023 21:30 | FY 2022 Earnings Call |
| 15/02/2023 21:05 | FY 2022 Earnings Release |
| 11/01/2023 01:15 | JP Morgan Healthcare Conference - Panel |
| 09/01/2023 15:30 | JP Morgan Healthcare Conference |
| 08/12/2022 17:00 | Investor Day |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 246 240 2.26% | 299 287 4.16% | 490 494 -0.65% | 516 508 1.63% | 619 617 0.32% | 678 |
|
EBITDA Million USD | Released Forecast Spread | -23,5 -27,6 14.97% | -520 -134 -288.43% | -31,1 -27,4 -13.53% | -143 -161 11.59% | -230 -218 -5.21% | -148 |
|
EBIT Million USD | Released Forecast Spread | -30,6 -34,5 11.41% | -86,6 -144 39.92% | -52,9 -49,4 -7.11% | -168 -182 7.87% | -265 -248 -7.07% | -201 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -31,0 -39,0 20.43% | -534 -141 -278.12% | -53,7 -45,9 -17.06% | -162 -182 11.09% | -249 -241 -3.2% | -189 |
|
Net income Million USD | Released Forecast Spread | -31,3 -37,1 15.85% | -543 -156 -247.3% | -58,2 -46,2 -25.94% | -166 -184 9.93% | -255 -244 -4.53% | -188 |
|
EPS USD | Released Forecast Spread | -0,80 -0,38 -111.56% | -5,37 -1,51 -254.54% | -0,53 -0,46 -15.64% | -1,46 -1,63 10.3% | -2,18 -2,11 -3.45% | -1,58 |
| Announcement Date | 18/02/20 | 17/02/21 | 16/02/22 | 15/02/23 | 15/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 144 148 -3.34% | 114 113 1.03% | 115 116 -1.11% | 131 129 1.51% | 156 148 5.44% | 134 129 4.2% | 147 140 4.87% | 154 151 1.56% | 184 184 0.13% | 142 | 157 | 177 | 202 | 173 |
|
EBITDA Million USD | Released Forecast Spread | -10,0 -4,00 -151.23% | -35,5 -36,1 1.45% | -56,6 -34,0 -66.52% | -33,8 -41,8 19.14% | -16,6 -31,1 46.68% | -45,5 -34,1 -33.55% | -53,4 -40,8 -30.8% | -85,4 -44,1 -93.71% | -45,5 -34,0 -33.9% | -38,4 | -41,5 | -32,6 | -17,6 | -42,8 |
|
EBIT Million USD | Released Forecast Spread | -15,8 -7,95 -99.12% | -41,7 -36,1 -15.71% | -63,1 -43,6 -44.72% | -40,0 -50,5 20.85% | -23,1 -35,7 35.22% | -52,0 -43,6 -19.29% | -63,4 -46,6 -35.98% | -94,8 -53,7 -76.62% | -55,2 -44,2 -24.75% | -61,2 | -60,4 | -48,5 | -33,7 | -46,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,0 -7,00 -128.47% | -41,7 -41,0 -1.69% | -63,8 -42,6 -50.01% | -40,0 -57,0 29.7% | -16,4 -37,1 55.8% | -49,7 -39,7 -25.16% | -60,8 -48,2 -26.19% | -91,7 -52,4 -74.93% | -46,6 -42,9 -8.53% | -59,2 | -56,4 | -46,0 | -30,1 | -48,8 |
|
Net income Million USD | Released Forecast Spread | -18,4 -4,85 -280.57% | -42,4 -37,3 -13.82% | -64,5 -43,7 -47.38% | -41,9 -50,5 16.98% | -17,2 -34,2 49.73% | -50,7 -43,4 -17.01% | -62,4 -44,8 -39.23% | -93,0 -52,1 -78.6% | -49,0 -40,8 -20.12% | -58,3 | -55,4 | -44,3 | -29,1 | -49,2 |
|
EPS USD | Released Forecast Spread | -0,16 -0,08 -112% | -0,38 -0,31 -21.54% | -0,57 -0,36 -57.79% | -0,37 -0,48 22.73% | -0,15 -0,32 52.49% | -0,44 -0,38 -16.53% | -0,53 -0,40 -31.38% | -0,79 -0,46 -71.75% | -0,41 -0,36 -15.34% | -0,50 | -0,47 | -0,38 | -0,25 | -0,41 |
| Announcement Date | 16/02/22 | 04/05/22 | 08/08/22 | 02/11/22 | 15/02/23 | 03/05/23 | 03/08/23 | 02/11/23 | 15/02/24 | - | - | - | - | - |
More events
Past sector events for 10x Genomics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TXG Stock
- Calendar 10x Genomics, Inc.
